Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Subtenon Administration of Autologous Adipose-Derived Regenerative Cells for Treatment of Glaucomatous Neurodegeneration

NCT02144103 is registered in ClinicalTrials.gov with Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation as lead sponsor.

NCT NCT02144103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02144103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Subtenon Administration of Autologous Adipose-Derived Regenerative Cells for Treatment of Glaucomatous Neurodegeneration
Lead sponsor
Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation
Phase
Phase 1/2
Overall status
Unknown status
Start date
May 31, 2014
Completion date
January 31, 2019
Enrollment
16 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

primary open-angle glaucoma, retinal degeneration